Evidence map›Paper›PMID 42564948›Full record

ArticleCell insight2026

Febrile-range temperature selectively limits sustained pDC-Derived IFN-α via attenuation of STAT1-Dependent feedback signaling.

Yangyang Xu, Hao Yang, Lin Yang, Qing Zhang, Liang Cheng

Abstract read
In one paragraph

Article in Cell insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yangyang XuDepartment of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, State Key Laboratory of Virology and Biosafety, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.
Hao YangDepartment of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, State Key Laboratory of Virology and Biosafety, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.
Lin YangDepartment of General Surgery, General Hospital of Xuzhou Mining Group, Xuzhou, 221000, Jiangsu, China.
Qing ZhangCancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
Liang ChengDepartment of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, State Key Laboratory of Virology and Biosafety, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) are specialized sentinels of antiviral immunity and the dominant early source of interferon-α (IFN-α) during viral infection. While pDC-derived IFN-α restricts viral replication and provides a critical third signal for T cell activation, sustained type I interferon (IFN-I) signaling can drive immunopathology, and the physiological mechanisms that constrain this response remain incompletely understood. Here, we identify fever as a conserved host factor that selectively limits IFN-α production by pDCs. We show that febrile-range temperature does not impair early IFN-α induction but instead suppresses sustained IFN-α output in human and mouse pDCs. Mechanistically, elevated temperature attenuates signal transducer and activator of transcription 1 (STAT1) phosphorylation, thereby disrupting the IFN-I-dependent positive feedback loop required for IFN-I amplification following CpG-A stimulation. Pharmacological inhibition of protein phosphatase activity with okadaic acid (OA) restores STAT1 phosphorylation and rescues IFN-α production under febrile conditions. Together, these findings establish fever as a physiological regulator of pDC-derived IFN-I responses and reveal a temperature-dependent mechanism that constrains prolonged IFN-I production to prevent excessive immune activation.

Indexed as

Febrile temperatureInterferon-αpDCSTAT1 phosphorylation

Identifiers

PMID42564948
PMCPMC13445209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.